Torsemide vs Furosemide in Heart Failure Treatment

Pharmacological Differences

• Torsemide has greater oral bioavailability compared to furosemide, making its absorption more predictable and consistent, especially important in patients with intestinal edema from heart failure 1, 3
• Torsemide has a longer duration of action than furosemide, potentially allowing for more sustained diuretic effect 2, 3
• Preclinical and clinical data suggest torsemide may have favorable modulation effects on the renin-angiotensin-aldosterone system (RAAS) with possible underlying disease modification effects in heart failure 1

Clinical Application

• Loop diuretics remain the cornerstone of volume management in heart failure and should be combined with guideline-directed medical therapy including ACE inhibitors and beta-blockers, as recommended by the American College of Cardiology and the American Heart Association 4, 5
• The usual daily dose range for torsemide is 10-20 mg compared to 40-240 mg for furosemide, according to the European Society of Cardiology 6
• Diuretic dosing should be adjusted to eliminate clinical evidence of fluid retention while monitoring for electrolyte imbalances, hypotension, and azotemia, as suggested by the American College of Cardiology 3, 2

Practical Considerations

• Consider switching from furosemide to torsemide in patients with variable or unpredictable response to furosemide, intestinal edema, or need for more consistent diuretic effect throughout the day, as recommended by the American College of Cardiology 3, 2
• Caution: When switching between loop diuretics, be aware that 10-20 mg of torsemide is approximately equivalent to 40-80 mg of furosemide, according to the European Heart Journal 6
• Monitor for electrolyte imbalances, especially hypokalemia and hypomagnesemia, with either agent, as suggested by the American College of Cardiology 3